Sigma Planning Corp’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,111
| Closed | -$214K | – | 1208 |
|
|
2024
Q2 | $214K | Sell |
9,111
-1,757
| -16% | -$41.3K | 0.01% | 1059 |
|
|
2024
Q1 | $313K | Buy |
+10,868
| New | +$313K | 0.01% | 943 |
|
|
2023
Q4 | – | Sell |
-11,867
| Closed | -$331K | – | 850 |
|
|
2023
Q3 | $331K | Buy |
11,867
+109
| +0.9% | +$3.04K | 0.01% | 884 |
|
|
2023
Q2 | $401K | Sell |
11,758
-2,222
| -16% | -$75.8K | 0.01% | 827 |
|
|
2023
Q1 | $420K | Buy |
13,980
+303
| +2% | +$9.11K | 0.01% | 875 |
|
|
2022
Q4 | $386K | Sell |
13,677
-2,995
| -18% | -$84.6K | 0.01% | 872 |
|
|
2022
Q3 | $548K | Buy |
16,672
+936
| +6% | +$30.8K | 0.02% | 693 |
|
|
2022
Q2 | $496K | Sell |
15,736
-3,857
| -20% | -$122K | 0.02% | 749 |
|
|
2022
Q1 | $900K | Sell |
19,593
-25,263
| -56% | -$1.16M | 0.03% | 580 |
|
|
2021
Q4 | $2.75M | Sell |
44,856
-6,366
| -12% | -$390K | 0.08% | 262 |
|
|
2021
Q3 | $3.83M | Sell |
51,222
-12,174
| -19% | -$910K | 0.12% | 191 |
|
|
2021
Q2 | $5.86M | Sell |
63,396
-13,146
| -17% | -$1.22M | 0.17% | 124 |
|
|
2021
Q1 | $6.79M | Sell |
76,542
-27,350
| -26% | -$2.43M | 0.22% | 103 |
|
|
2020
Q4 | $9.69M | Buy |
103,892
+4,059
| +4% | +$379K | 0.33% | 62 |
|
|
2020
Q3 | $6.36M | Sell |
99,833
-9,212
| -8% | -$587K | 0.25% | 78 |
|
|
2020
Q2 | $5.69M | Buy |
109,045
+96,557
| +773% | +$5.04M | 0.25% | 79 |
|
|
2020
Q1 | $391K | Sell |
12,488
-3,031
| -20% | -$94.9K | 0.02% | 559 |
|
|
2019
Q4 | $520K | Buy |
15,519
+4,291
| +38% | +$144K | 0.02% | 579 |
|
|
2019
Q3 | $331K | Buy |
11,228
+3,673
| +49% | +$108K | 0.02% | 715 |
|
|
2019
Q2 | $260K | Buy |
+7,555
| New | +$260K | 0.01% | 790 |
|